The European Medicines Agency (EMA) published a text on its website highlighting the concerns and questions that arise, as well as the false claims related to vaccines. In the relevant…
News
-
-
An experimental gene therapy developed by UCLA, University College London, and Great Ormond Street Hospital has successfully restored immune function in 59 of 62 children born with ADA-SCID, a rare…
-
A single-dose gene therapy has demonstrated remarkable results in slowing the advancement of Huntington’s disease during a preliminary trial, according to a press release from University College London (UCL). Researchers…
-
The presentation of the Multiparametric Microscopic and Functional Analysis for the Screening of Pharmaceutical Compounds was conducted with interest, as part of the completion of the Scientific Project “DiseasePHENOTarget,” on…
-
The Long-Awaited Three-Year Study Results on Huntington’s Disease AMT-130, uniQure’s gene therapy, would be the first genetic treatment for Huntington’s disease, if approved. The observed slowing of disease progression is…
-
CRISPR is being significantly enhanced thanks to DNA-coated nanostructures, which improve the delivery and precision of gene editing, paving the way for safer genetic medicine. Scientists from Northwestern University (USA)…
-
5th Congress of Cellular And Instrumental Regenerative Medicine Organization: IMSARM, Switzerland When: October 3rd and 4th, 2025 Where: Strasbourg, France HILTON Hotel In 5th congress in Regenerative Medicine in…
-
The following review from Gene Therapy of Nature presents the advances and future prospects of gene editing in relation to collagen disorders. Collagen disorders include a broad spectrum of inherited…
-
A research group funded by the National Institutes of Health (NIH) has successfully created and delivered a personalized gene-editing therapy to treat an infant suffering from a life-threatening, previously untreatable…
-
After the completion of the electronic voting by the Regular members of the Greek Society of Gene Therapy and Regenerative Medicine (HSGTRM), from June 25 to July 2, 2025, and…
Newer Posts